The use of corticosteroids for COVID-19 infection
Afr. j. med. med. sci
; 26(3): 1-3, 2020.
Article
in English
| AIM
| ID: biblio-1257346
Responsible library:
CG1.1
ABSTRACT
The SARS-CoV-2 pandemic is continuing relentlessly in many parts of the world and has resulted in the outpouring of literature on various aspects of the infection, including studies and recommendations regarding the optimal treatment of infected patients. Not surprisingly, the use of corticosteroids in the management of such patients has featured prominently in many of these publications. There is considerable debate in the literature as to the likely benefits, as well as the potential detrimental effects of corticosteroid therapy in general viral respiratory infections and, in particular, COVID-19 infections. While the definitive answer may need to await the results of ongoing randomised, controlled trials recent studies suggest that corticosteroid use in COVID-19 cases with hypoxaemia may benefit from low-dose corticosteroid therapy
Search on Google
Index:
AIM (Africa)
Main subject:
South Africa
/
Adrenal Cortex Hormones
/
Coronavirus Infections
/
Severe acute respiratory syndrome-related coronavirus
/
COVID-19
Type of study:
Controlled clinical trial
/
Practice guideline
Country/Region as subject:
Africa
Language:
English
Journal:
Afr. j. med. med. sci
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS